Impact of splenomegaly on therapeutic response and I-131-LYM-1 dosimetry in patients with B-lymphocytic malignancies.
Shen, S
Impact of splenomegaly on therapeutic response and I-131-LYM-1 dosimetry in patients with B-lymphocytic malignancies. [electronic resource] - Cancer Dec 1997 - 2553-7 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0008-543X
10.1002/(sici)1097-0142(19971215)80:12+<2553::aid-cncr30>3.3.co;2-n doi
Humans
Iodine Radioisotopes--therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell--radiotherapy
Lymphoma, Non-Hodgkin--radiotherapy
Radioimmunotherapy
Radiotherapy Dosage
Splenomegaly--metabolism
Impact of splenomegaly on therapeutic response and I-131-LYM-1 dosimetry in patients with B-lymphocytic malignancies. [electronic resource] - Cancer Dec 1997 - 2553-7 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0008-543X
10.1002/(sici)1097-0142(19971215)80:12+<2553::aid-cncr30>3.3.co;2-n doi
Humans
Iodine Radioisotopes--therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell--radiotherapy
Lymphoma, Non-Hodgkin--radiotherapy
Radioimmunotherapy
Radiotherapy Dosage
Splenomegaly--metabolism